Received May 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | — | — |
No other AE/No PQC; Patient did have all childhood vaccinations at the time that they were due when she was a child so this PEDVAXHIB is an extra dose; This spontaneous report was received from a nurse regarding to a 22-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 28-MAY-2025, the patient was vaccinated with haemophilus b Conjugate Vaccine (meningococcal protein conjugate) (LIQUID PEDVAX HIB) at a dose of 0.5 mL (strength, route of administration, anatomical injection site, lot # and expiration date were not reported), for prophylaxis; and with hepatitis b vaccine rHBsAg (yeast) (ENGERIX B) (strength, dose, route of administration, anatomical injection site, lot #, expiration date and indication were not reported). The reporter stated that patient was inadvertently given haemophilus b Conjugate Vaccine (meningococcal protein conjugate) (LIQUID PEDVAX HIB) that was not due. The patient was also vaccinated with hepatitis b vaccine rHBsAg (yeast) (ENGERIX B) at the same time as the haemophilus b Conjugate Vaccine (meningococcal protein conjugate) (LIQUID PEDVAX HIB). Hepatitis b vaccine rHBsAg (yeast) (ENGERIX B) was due and was given appropriately. Patient did have all childhood vaccinations at the time that they were due when she was a child so this haemophilus b Conjugate Vaccine (meningococcal protein conjugate) (LIQUID PEDVAX HIB) was an extra dose. No other information provided. No other AE/No PQC. Lot # is being requested and will be submitted if received.